Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alcohol use and hepatitis C.

Marion G Peters1, Norah A Terrault

  • 1Department of Gastroenterology, University of California, San Francisco, CA 94143, USA. mpeters@itsa.ucsf.edu

Hepatology (Baltimore, Md.)
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating metabolic dysfunction-associated steatotic liver disease, associated adverse pregnancy outcomes, and postpartum maternal course utilising transient elastography with controlled attenuation parameter in pregnancy: a prospective cohort study.

The Lancet. Obstetrics, gynaecology, & women's health·2026
Same author

Reply.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

National trends in resmetirom prescriptions for metabolic dysfunction-associated steatohepatitis in the USA.

Clinical and molecular hepatology·2026
Same author

Differential gastrointestinal mortality in Native Hawaiian/Pacific Islander and Asian subgroups in the U.S.: a cross-sectional analysis of national mortality surveillance data 2018-2023.

Lancet regional health. Americas·2026
Same author

Evaluation of Liver Fibrosis Change After DAA-induced Cure of Hepatitis C in Participants With and Without HIV: ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (VHICS).

Open forum infectious diseases·2026
Same author

Long-term considerations following living liver donation-Guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025
Same journal

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

Hepatology (Baltimore, Md.)·2026
Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

Hepatology (Baltimore, Md.)·2026
Same journal

H4K12 lactylation drives TREM2high macrophages differentiation in liver fibrosis.

Hepatology (Baltimore, Md.)·2026
Same journal

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

One size does not fit all: Global variability in noninvasive testing for MASLD.

Hepatology (Baltimore, Md.)·2026
See all related articles

Heavy alcohol consumption worsens hepatitis C outcomes. More research is needed on how light to moderate alcohol intake affects hepatitis C virus (HCV) infection and treatment response.

Area of Science:

  • Hepatology
  • Virology
  • Addiction Medicine

Background:

  • Excessive alcohol intake is known to negatively impact chronic hepatitis C progression and outcomes.
  • Distinguishing alcohol abuse from alcohol's effect on hepatitis C is crucial for effective management.
  • Limited research exists on the effects of light to moderate alcohol consumption on hepatitis C virus (HCV) infection.

Purpose of the Study:

  • To review the current literature on the effects of alcohol consumption on hepatitis C.
  • To identify knowledge gaps regarding light to moderate alcohol intake and hepatitis C.
  • To explore sex differences in alcohol's impact on hepatitis C severity and fibrosis.

Main Methods:

  • Literature review of studies examining alcohol consumption and hepatitis C.

Related Experiment Videos

  • Analysis of data focusing on alcohol intake levels (heavy vs. light/moderate).
  • Examination of reported effects on fibrosis, disease severity, treatment response, and viral load.

    • Main Results:

    • Heavy alcohol intake is consistently linked to worse outcomes in chronic hepatitis C.
    • Evidence regarding adverse effects of light to moderate alcohol intake on HCV infection is limited and inconclusive.
    • Alcohol use may be associated with reduced treatment response rates and increased HCV RNA levels.

    Conclusions:

    • Heavy alcohol consumption clearly exacerbates hepatitis C outcomes.
    • Definitive recommendations for light to moderate alcohol use in hepatitis C patients cannot be made due to insufficient evidence.
    • Further research is required to elucidate the precise impact of varying alcohol consumption levels on hepatitis C progression and treatment.